Nanjo, Shigeki
Hata, Akito
Okuda, Chiyuki
Kaji, Reiko
Okada, Hideaki
Tamura, Daisuke
Irie, Kei
Okada, Hiroshi
Fukushima, Shoji
Katakami, Nobuyuki
Article History
Received: 29 April 2017
Revised: 28 September 2017
Accepted: 9 October 2017
First Online: 30 November 2017
Change Date: 9 January 2018
Change Type: Update
Change Details: This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Competing interests
: AH received lecture fees from Chugai, Astra Zeneca, Boeringer Ingelheim, and Eli Lilly. NK received grants from Astra Zeneca, Eisai, Ono, Kyowa Kirin, Shionogi, Daiichi-Sankyo, Taiho, Chugai, Eli Lilly, Boeringer Ingelheim, and Merck Serono, and payment for lectures from Dainippon Sumitomo, Chugai, Boeringer Ingelheim, Astra Zeneca, Eli Lilly, Taiho, Janssen, Novartis, Pfizer, Ono, and Daiichi-Sankyo. All other authors declare no conflict of interest.